Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis

References

• CeelenWFierensKVan NieuwenhoveYPattynPPreoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: a systematic review and meta-analysisInt J Cancer2009124122966297219253365
   PubMed Web of Science ®Google Scholar
• SongJHJeongJULeeJHPreoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II-III resectable rectal cancer: a meta-analysis of randomized controlled trialsRadiat Oncol J201735319820729037017
   PubMedGoogle Scholar
• BossetJFColletteLCalaisGChemotherapy with preoperative radiotherapy in rectal cancerN Engl J Med2006355111114112316971718
   PubMed Web of Science ®Google Scholar
• SchouJVLarsenFORaschLInduction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before total mesorectal excision in patients with locally advanced rectal cancerAnn Oncol201223102627263322473488
   PubMed Web of Science ®Google Scholar
• KimSYKimTWHongYSA randomized phase II trial of consolidation chemotherapy after preoperative chemoradiation (preop CRT) versus CRT alone for locally advanced rectal cancer (LARC)Journal of Clinical Oncology201735153606
   Google Scholar
• Glynne-JonesRHavaNGohVBevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectumBMC Cancer201515176426493588
   PubMedGoogle Scholar
• MaasMNelemansPJValentiniVLong-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient dataLancet Oncol201011983584420692872
   PubMed Web of Science ®Google Scholar
• KuoLJLiuMCJianJJIs final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?Ann Surg Oncol200714102766277217551794
   PubMed Web of Science ®Google Scholar
• Habr-GamaASão JuliãoGPVailatiBBCastroIRaffaeleDManagement of the complete clinical responseClin Colon Rectal Surg201730538739429184475
   PubMed Web of Science ®Google Scholar
• DattaniMHealdRJGoussousGOncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancerAnn Surg2018268695596729746338
   PubMed Web of Science ®Google Scholar
• HoaglinDCHawkinsNJansenJPConducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR task force on indirect treatment comparisons good research practices: part 2Value Health201114442943721669367
   PubMed Web of Science ®Google Scholar
• HigginsJPTAltmanDGGotzschePCThe cochrane collaboration’s tool for assessing risk of bias in randomised trialsBMJ2011343d592822008217
   PubMed Web of Science ®Google Scholar
• WiśniowskaKNasierowska-GuttmejerAPolkowskiWDoes the addition of oxaliplatin to preoperative chemoradiation benefit cT4 or fixed cT3 rectal cancer treatment? A subgroup analysis from a prospective studyEur J Surg Oncol201642121859186527546011
   PubMed Web of Science ®Google Scholar
• O’ConnellMJColangeloLHBeartRWCapecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04J Clin Oncol201432181927193424799484
   PubMed Web of Science ®Google Scholar
• SahaAGhoshSKRoyCSahaMLChoudhuryKBChatterjeeKA randomized controlled pilot study to compare capecitabineoxaliplatin with 5-FU-leucovorin as neoadjuvant concurrent chemoradiation in locally advanced adenocarcinoma of rectumJ Cancer Res Ther20151118825879343
   PubMed Web of Science ®Google Scholar
• KayalPKSahaADastidarAGMahataADasASarkarRA randomized comparative study between neoadjuvant 5-fluorouracil and leukovorin versus 5-fluorouracil and cisplatin along with concurrent radiation in locally advanced carcinoma rectumClin Cancer Investig J2014313237
   Google Scholar
• HaddadPMiraieMFarhanFAddition of oxaliplatin to neoadjuvant radiochemotherapy in MRI-defined T3, T4 or N+ rectal cancer: a randomized clinical trialAsia Pac J Clin Oncol201713641642228488380
   PubMed Web of Science ®Google Scholar
• HofheinzRDWenzFPostSChemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trialLancet Oncol201213657958822503032
   PubMed Web of Science ®Google Scholar
• DengYChiPLanPModified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer: initial results of the chinese FOWARC multicenter, open-label, randomized three-arm phase III trialJ Clin Oncol201634273300330727480145
   PubMed Web of Science ®Google Scholar
• GérardJPAzriaDGourgou-BourgadeSComparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2J Clin Oncol201028101638164420194850
   PubMed Web of Science ®Google Scholar
• MohiuddinMWinterKMitchellERandomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: radiation therapy oncology group trial 0012J Clin Oncol200624465065516446336
   PubMed Web of Science ®Google Scholar
• RödelCLierschTBeckerHPreoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trialLancet Oncol201213767968722627104
   PubMed Web of Science ®Google Scholar
• SterneJAGavaghanDEggerMPublication and related bias in meta-analysis: power of statistical tests and prevalence in the literatureJ Clin Epidemiol200053111119112911106885
   PubMed Web of Science ®Google Scholar
• CopasJBShiJQA sensitivity analysis for publication bias in systematic reviewsStat Methods Med Res200110425126511491412
   PubMed Web of Science ®Google Scholar
• CiprianiAHigginsJPGeddesJRSalantiGConceptual and technical challenges in network meta-analysisAnn Intern Med2013159213013723856683
   PubMed Web of Science ®Google Scholar
• Meta-analysis Group In CancerPiedboisPRougierPEfficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancerJ Clin Oncol19981613013089440757
   PubMed Web of Science ®Google Scholar
• DunstJReeseTSutterTPhase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancerJ Clin Oncol200220193983399112351595
   PubMed Web of Science ®Google Scholar
• LiuGCYanJPHeQAnXPanZZDingPREffect of neoadjuvant chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a meta-analysisGastroenterol Res Pract201620166110
   Google Scholar
• KouroussisCSouglakosJKakolyrisSOxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: a phase II studyOncology2001611364111474246
   PubMed Web of Science ®Google Scholar
• AndréTBoniCNavarroMImproved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trialJ Clin Oncol200927193109311619451431
   PubMed Web of Science ®Google Scholar
• ZhengJFengXHuWWangJLiYSystematic review and meta-analysis of preoperative chemoradiotherapy with or without oxaliplatin in locally advanced rectal cancerMedicine20179613e648728353591
   PubMed Web of Science ®Google Scholar
• SuttonAAdesAECooperNAbramsKUse of indirect and mixed treatment comparisons for technology assessmentPharmacoeconomics200826975376718767896
   PubMed Web of Science ®Google Scholar
• SongFAltmanDGGlennyAMDeeksJJValidity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analysesBMJ2003326738747212609941
   PubMed Web of Science ®Google Scholar
• AscheleCCioniniLLonardiSPrimary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trialJ Clin Oncol201129202773278021606427
   PubMed Web of Science ®Google Scholar
• JiaoDZhangRGongZFluorouracil-based preoperative chemoradiotherapy with or without oxaliplatin for stage II/III rectal cancer: a 3-year follow-up studyChin J Cancer Res201527658859626752933
   PubMed Web of Science ®Google Scholar
• JungMShinSJKoomWSA randomized phase 2 study of neoadjuvant chemoradiaton therapy with 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in patients with locally advanced rectal cancerInt J Radiat Oncol Biol Phys20159351015102226581140
   PubMed Web of Science ®Google Scholar
• WongSJWinterKMeropolNJRadiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancerInt J Radiat Oncol Biol Phys20128241367137521775070
   PubMed Web of Science ®Google Scholar